http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2528738-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09ca043d7e596facff1f44b746e2f4d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-49 |
| filingDate | 2004-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d70773f698aa2790c6912b8e8203396a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac0d1b4afd1f6324f1aae4100ad7f7b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eefd96c504ca2e21531e3b80271a8ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eeb60836bc52402e9d3243824e01110 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9d964d9e935ce2f38b350eef6024d5c |
| publicationDate | 2015-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2528738-T3 |
| titleOfInvention | Method to enhance the efficacy of a preparation of a monoclonal antibody |
| abstract | A method of enhancing the efficacy of a monoclonal antibody preparation, wherein said monoclonal antibody is an antibody that recognizes human immunodeficiency virus type 1 (HIV-1) as an antigen, comprising selecting suitable patients for the administration of said preparation. of monoclonal antibody by previously analyzing an amino acid sequence of an antigenic protein of a target molecule present in a patient sample, where said method comprises the steps: (1) deducing an amino acid sequence of a protein expressed in patients from a nucleotide sequence of a gene of a determined target molecule by means of isolation and analysis of said gene in the biopsy of patients; (2) evaluating the suitability of patients for administration of said monoclonal antibody preparation by comparing the deduced amino acid sequence in step (1) with an amino acid sequence that is recognizable by said monoclonal antibody as previously determined; and (3) select patients to whom to administer said monoclonal antibody preparation with its predicted efficacy based on the suitability evaluated in step (2). |
| priorityDate | 2003-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 171.